Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 1
2009 1
2015 1
2016 3
2017 6
2018 9
2019 12
2020 7
2021 14
2022 19
2023 14
2024 18
2025 14
2026 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Results by year

Filters applied: . Clear all
Page 1
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.
Iuliano AD, Roguski KM, Chang HH, Muscatello DJ, Palekar R, Tempia S, Cohen C, Gran JM, Schanzer D, Cowling BJ, Wu P, Kyncl J, Ang LW, Park M, Redlberger-Fritz M, Yu H, Espenhain L, Krishnan A, Emukule G, van Asten L, Pereira da Silva S, Aungkulanon S, Buchholz U, Widdowson MA, Bresee JS; Global Seasonal Influenza-associated Mortality Collaborator Network. Iuliano AD, et al. Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14. Lancet. 2018. PMID: 29248255 Free PMC article.
Interim 2024/25 influenza vaccine effectiveness: eight European studies, September 2024 to January 2025.
Rose AM, Lucaccioni H, Marsh K, Kirsebom F, Whitaker H, Emborg HD, Bolt Botnen A, O'Doherty MG, Pozo F, Hameed SS, Andrews N, Hamilton M, Trebbien R, Lauenborg Møller K, Marques DF, Murphy S, McQueenie R, Lopez-Bernal J, Cottrell S, Bucholc M, Kissling E; European IVE group; Members of the European IVE group. Rose AM, et al. Euro Surveill. 2025 Feb;30(7):2500102. doi: 10.2807/1560-7917.ES.2025.30.7.2500102. Euro Surveill. 2025. PMID: 39980423 Free PMC article.
New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic.
Teirlinck AC, Johannesen CK, Broberg EK, Penttinen P, Campbell H, Nair H, Reeves RM, Bøås H, Brytting M, Cai W, Carnahan A, Casalegno JS, Danis K, De Gascun C, Ellis J, Emborg HD, Gijon M, Guiomar R, Hirve SS, Jiřincová H, Nohynek H, Oliva JA, Osei-Yeboah R, Paget J, Pakarna G, Pebody R, Presser L, Rapp M, Reiche J, Rodrigues AP, Seppälä E, Socan M, Szymanski K, Trebbien R, Večeřová J, van der Werf S, Zambon M, Meijer A, Fischer TK. Teirlinck AC, et al. Among authors: rodrigues ap. Eur Respir J. 2023 Apr 3;61(4):2201569. doi: 10.1183/13993003.01569-2022. Print 2023 Apr. Eur Respir J. 2023. PMID: 37012081 Free PMC article.
Effectiveness of the XBB.1.5 COVID-19 Vaccines Against SARS-CoV-2 Hospitalisation Among Adults Aged ≥ 65 Years During the BA.2.86/JN.1 Predominant Period, VEBIS Hospital Study, Europe, November 2023 to May 2024.
Antunes L, Rojas-Castro M, Lozano M, Martínez-Baz I, Leroux-Roels I, Borg ML, Oroszi B, Fitzgerald M, Dürrwald R, Jancoriene L, Machado A, Petrović G, Lazar M, Součková L, Bacci S, Howard J, Verdasca N, Basile L, Castilla J, Ternest S, Džiugytė A, Túri G, Duffy R, Hackmann C, Kuliese M, Gomez V, Makarić ZL, Marin A, Husa P, Nicolay N, Rose AMC; VEBIS SARI VE network team. Antunes L, et al. Influenza Other Respir Viruses. 2025 Mar;19(3):e70081. doi: 10.1111/irv.70081. Influenza Other Respir Viruses. 2025. PMID: 40059069 Free PMC article.
Effectiveness of long-acting monoclonal antibodies against laboratory-confirmed RSV in children aged < 24 months and hospitalised for severe acute respiratory infection, European pilot study, 2024 to 2025.
Savulescu C, Ganser I, Nicolay N, Lajot A, Campos S, Martínez-Baz I, Rodrigues AP, Vandromme M, Cara-Rodríguez M, Echeverría A, Gaio V, Parsy MP, Roldan Garrido A, Castilla J, Guiomar R, Bacci S, Rose AM; VEBIS hospital network RSV IE group. Savulescu C, et al. Among authors: rodrigues ap. Euro Surveill. 2025 Nov;30(45):2500816. doi: 10.2807/1560-7917.ES.2025.30.45.2500816. Euro Surveill. 2025. PMID: 41234196 Free PMC article.
COVID-19 Vaccine Effectiveness Against Medically Attended Symptomatic SARS-CoV-2 Infection Among Target Groups in Europe, October 2024-January 2025, VEBIS Primary Care Network.
Laniece Delaunay C, Verdasca N, Monge S, Domegan L, Sève N, Buda S, Meijer A, Lucaccioni H, López Torrijos M, McKenna A, Enouf V, Dürrwald R, In't Velt E, de Valcárcel Laiglesia MÁ, Bennett C, Masse S, Erdwiens A, Hooiveld M, Mlinarić I, Túri G, Rodrigues AP, Martínez-Baz I, Lazar M, Latorre-Margalef N, Borges V, Kaczmarek M, Bacci S, Kissling E; European primary care VE group. Laniece Delaunay C, et al. Among authors: rodrigues ap. Influenza Other Respir Viruses. 2025 May;19(5):e70120. doi: 10.1111/irv.70120. Influenza Other Respir Viruses. 2025. PMID: 40395132 Free PMC article.
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24.
Kissling E, Maurel M, Pozo F, Pérez-Gimeno G, Buda S, Sève N, Domegan L, Hooiveld M, Oroszi B, Martínez-Baz I, Guiomar R, Latorre-Margalef N, Mlinarić I, Lazar M, Giménez Duran J, Dürrwald R, Enouf V, McKenna A, de Lange M, Túri G, Trobajo-Sanmartín C, Gomez V, Samuelsson Hagey T, Višekruna Vučina V, Cherciu MC, García Vazquez M, Erdwiens A, Masse S, Bennett C, Meijer A, Kristóf K, Castilla J, Rodrigues AP, Kurečić Filipović S, Ivanciuc AE, Bacci S, Kaczmarek M; European primary care VE group. Kissling E, et al. Among authors: rodrigues ap. Euro Surveill. 2025 Jun;30(23):2500011. doi: 10.2807/1560-7917.ES.2025.30.23.2500011. Euro Surveill. 2025. PMID: 40511473 Free PMC article.
Vaccine effectiveness against influenza A in older adults and the effect of chronic conditions: results from the I-MOVE and VEBIS multicentre European hospital case-control studies, 2015/16-2023/24.
Rose AMC, Nicolay N, Mazagatos C, Martínez-Baz I, Launay O, De Mot L, Bella A, Lazar M, Machado A, Kuliešė M, Abela S, Vučina VV, van Gageldonk-Lafeber R, Bino S, Dürrwald R, Paradowska-Stankiewicz I, Horváth JK, Duffy R, Husa P, McMenamin J, Pozo F, Howard J, Latorre-Millán M, Castilla J, Nguyen LBL, Dauby N, Riccardo F, Ivanciuc A, Gomez V, Jančorienė L, Xuereb G, Petrović G, Marbus S, Vasili A, Tolksdorf K, Bogusz J, Oroszi B, Domegan L, Součková L, Marsh K, Bacci S, Kissling E; I-MOVE & VEBIS Hospital Network teams. Rose AMC, et al. BMC Med. 2025 Nov 3;23(1):602. doi: 10.1186/s12916-025-04426-y. BMC Med. 2025. PMID: 41185010 Free PMC article.
Nirsevimab Effectiveness Against RSV-Related Hospitalisations in Children Under 24 Months: A Test-Negative Case-Control Study in Portugal, 2024-2025.
Gaio V, Henriques C, Lança M, Marques R, Marques R, Rodrigues M, Almeida S, Sousa B, Freitas M, Amaral D, Ferreira S, Azevedo I, von Hafe M, Gonçalves R, Viseu R, Bandeira T, Constant C, Malato M, Carvalho I, Rodrigues J, Farinha M, Nunes T, Graça T, Gomez S, Soares S, Neves JF, Paixão P, Piscalho I, Loureiro A, Freitas C, Alves J, Soares D, Lopes P, Machado A, Guiomar R, Rodrigues AP; VigiRSV Group. Gaio V, et al. Among authors: rodrigues ap. Influenza Other Respir Viruses. 2025 Dec;19(12):e70186. doi: 10.1111/irv.70186. Influenza Other Respir Viruses. 2025. PMID: 41320971 Free PMC article.
119 results